Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefaliv vs Neosaldina for Migraine Attacks
NCT02706015Phase 3Withdrawn
- Sponsor
- Aché Laboratórios Farmacêuticos
- Start
- Oct 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Cefaliv in migraine, sponsored by Aché Laboratórios Farmacêuticos. Planned start Oct 2020; status: withdrawn.
02
Drugs
Cefaliv
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02706015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02706015.